Researchers reporting in ACS Central Science have created a novel treatment that eliminated small breast tumors and significantly shrank large tumors in mice in a single dose, without problematic side effects.

The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or metastatic hormone receptor HR+, HER2- breast cancer in adult patients who have previously received endocrine-based therapy and chemotherapy for unresectable or metastatic disease, according to a news release.

Danielle Fishel is sharing an update about her health, saying she has completed “active cancer treatment” following her announcement in August that she was diagnosed with DCIS, which stands for ductal carcinoma in situ and is a form of breast cancer.

The Breast Cancer Risk Assessment Tool (BCRAT), also known as The Gail Model, is a tool used by healthcare professionals to estimate a woman's risk of developing invasive breast cancer within the next five years and within her lifetime (up to age 90), according to the National Cancer Institute.

Breast Cancer Now said the treatment, which is also known as Lynparza, will be an “valuable alternative” for patients. The National Institute for Health and Care Excellence (Nice) said the drug can be used for “treating HER2-negative locally advanced ...

Use of long-acting, reversible contraceptives is associated with an increased risk of certain cancers, a study suggests.

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic and breast cancer.

Cancer diagnoses are shifting from older to younger adults and from men to women, according to a report released Thursday by the American Cancer Society.

Cancer researchers at the University of Leicester have developed a technique that could predict how well some breast cancer patients will respond to chemotherapy and antibody-directed cancer treatments.

Breast cancer remains the number one diagnosed cancer in women in the United States, other than skin cancer, according to the American Society of Clinical Oncology (ASCO). If you're concerned about breast cancer affecting you or someone close to you, this ...

An expert spoke with CURE about providers’ “two-fold goal” when using chemotherapy to treat patients with breast cancer.

The addition of anthracyclines to adjuvant taxane-based chemotherapy improved survival for certain high-risk patients with breast cancer, according to data presented at San Antonio Breast Cancer Symposium.